Type 1 Diabetes Research – Special Diabetes Program

Research Funding Opportunities - Current and Upcoming

This page shows current and upcoming funding opportunities supported by the Special Diabetes Program. For other NIH funding opportunities, please see the NIH Guide for Grants and Contracts. Research funding opportunities may also be available through the JDRF  Exit Disclaimer Icon , the Helmsley Trust  Exit Disclaimer Icon , and the American Diabetes Association Exit Disclaimer Icon.

View archived research funding opportunities.

Current


  • Bioengineering Interdisciplinary Training for Diabetes Research (T32)
    PAR-13-047
    Posted Date: December 17, 2012
    Open Date (Earliest Submission Date): February 7, 2013
    Letter of Intent Due Dates February 7, 2013 and October 26, 2013
    Application Receipt Dates: March 7, 2013 and November 26, 2013, by 5:00 PM local time of applicant organization

  • Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) Towards an Artifical Pancreas [SBIR (R43/R44)]
    RFA-DK-13-001
    Posted Date: December 17, 2012
    Open Date (Earliest Submission Date): February 6, 2013
    Letter of Intent Due Date: February 6, 2013
    Application Receipt Date: March 6, 2013 by 5:00PM local time of applicant organization

  • Diabetes Impact Award-Closed Loop Technologies: Clinical, Physiological and Behavioral Approaches to Improve Type 1 Diabetes Outcomes (DP3)
    RFA-DK-12-020
    Posted Date: December 12, 2012
    Open Date (Earliest Submission Date): February 28, 2013
    Letter of Intent Due Date: February 28, 2013
    Application Receipt Date: March 28, 2013 by 5:00PM local time of applicant organization

  • Diabetes Impact Award-Closed Loop Technologies: Development and Integration of Novel Components for an Automated Artificial Pancreas System (DP3)
    RFA-DK-12-021
    Posted Date: December 12, 2012
    Open Date (Earliest Submission Date): February 28, 2013
    Letter of Intent Due Date: February 28, 2013
    Application Receipt Date: March 28, 2013 by 5:00PM local time of applicant organization

  • Research Using Subjects From Selected Type 1 Diabetes Clinical Studies (Living Biobank) (DP3)
    PAR-13-028
    Posted Date: November 27, 2012
    Open Date (Earliest Submission Date): March 2, 2013
    Letter of Intent Due Date: March 2, 2013
    Application Receipt Date: April 2, 2013, by 5:00 PM local time of applicant organization

  • Collaborative Network for Clinical Research on Immune Tolerance (UM1)
    RFA-AI-12-043
    Posted Date: November 5, 2012
    Letter of Intent Due Date: February 7, 2013
    Application Receipt Date: March 7, 2013

  • Research Using Biosamples From Selected Type 1 Diabetes Clinical Studies (DP3)
    PAR-13-013
    Posted Date: October 30, 2012
    Open Date (Earliest Submission Date): March 2, 2013
    Letter of Intent Due Date: March 2, 2013
    Application Receipt Date: April 2, 2013, by 5:00 PM local time of applicant organization

  • Diabetic Complications Consortium Preclinical Testing Program  Exit Disclaimer Icon
    Application Receipt Date: There is no formal deadline, but applications will be reviewed quarterly (March 1, June 1, September 1, December 1) and so should be submitted accordingly

Upcoming


  • None at this time.

Last Updated: 5/15/2012

General Inquiries may be addressed to:
Office of Communications and Public Liaison
NIDDK, NIH
Building 31, Rm 9A06
31 Center Drive, MSC 2560
Bethesda, MD 20892-2560 USA
For information about NIDDK programs: 301.496.3583